Prostaglandin E1 administration post liver transplantation and renal outcomes: A retrospective single center experience
In patients who received PGE1 for ischemia-reperfusion injury, despite immediate acute renal injury post-LT, the renal function at 1-month, 6-months, and 12-months post-LT was similar compared to those without ischemia-reperfusion injury. Prospective clinical trials are needed to further elucidate the benefits of PGE1 use in renal function.
Authors
- Vinay Jahagirdar (ORCID: https://orcid.org/0000-0001-6685-1033)
- Matthew Wilkinson (ORCID: https://orcid.org/0000-0003-4932-4308)
- John H. Helzberg
- Alisa Likhitsup (ORCID: https://orcid.org/0000-0001-8191-9497)
- Ifrah Fatima (ORCID: https://orcid.org/0000-0002-6356-6859)
- Laura Alba
- Mohamed Ahmed (ORCID: https://orcid.org/0000-0003-3123-8399)
- Hassam Ali (ORCID: https://orcid.org/0000-0001-5546-9197)
- Lee S. Cummings
- Jameson Forster
Institutions
- Saint Luke's Health System (US)
- East Carolina University (US)
- University of Michigan (US)
- Michigan Medicine (US)
- Saint Luke's Hospital (US)
Publication Details
- Journal
- World Journal of Transplantation
- Published
- 2024-09-20
- DOI
- https://doi.org/10.5500/wjt.v14.i4.98797
- Primary Topic
- Organ Transplantation Techniques and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00